Chicago-Kent Journal of Intellectual Property
Volume 19
Issue 2 PTAB Bar Association

Article 3

1-28-2020

Discretionary Denials of IPR Institution
Jasper Tran
Jones Day, jaspertran@jonesday.com

Matthew Chung
UC Berkeley, matt.chung@berkeley.edu

David Maiorana
Jones Day, dmaiorana@jonesday.com

Matthew Johnson
Jones Day, mwjohnson@jonesday.com

Follow this and additional works at: https://scholarship.kentlaw.iit.edu/ckjip
Part of the Intellectual Property Law Commons

Recommended Citation
Jasper Tran, Matthew Chung, David Maiorana & Matthew Johnson, Discretionary Denials of IPR
Institution, 19 Chi. -Kent J. Intell. Prop. 253 (2020).
Available at: https://scholarship.kentlaw.iit.edu/ckjip/vol19/iss2/3

This Article is brought to you for free and open access by Scholarly Commons @ IIT Chicago-Kent College of Law.
It has been accepted for inclusion in Chicago-Kent Journal of Intellectual Property by an authorized editor of
Scholarly Commons @ IIT Chicago-Kent College of Law. For more information, please contact
jwenger@kentlaw.iit.edu, ebarney@kentlaw.iit.edu.

DISCRETIONARY DENIALS OF IPR INSTITUTION

12/26/2019 5:35 PM

DISCRETIONARY DENIALS OF IPR
INSTITUTION
Jasper L. Tran, Matthew Chung, David Maiorana, and Matthew W.
Johnson*
I. INTRODUCTION
On September 12, 2018, the PTAB in NHK Spring Co. v. Intri-Plex
Techs., Inc. exercised its discretion under 35 U.S.C. § 314(a)1 to deny
institution of an IPR, despite the petition’s timely filing, due to a parallel
district court trial scheduled six months after the date of filing.2 The PTAB
designated NHK Spring as precedential on May 7, 2019 and, in so doing,
characterized NHK Spring’s holding as denying institution because the copending district court proceeding was “nearing completion.”3 The PTAB
has “recognized in cases such as NHK Spring that the fact that [a] court
will resolve the same issues raised by [a] Petition, at an earlier date than the
Board, gives rise to inefficiencies and duplication of effort between the
tribunals.”4 By examining the effect of the designation of NHK Spring as

* The views set forth herein are personal and do not necessarily reflect those of Jones Day or its
former/current clients.
1. Section 314(a) reads: “Threshold. The Director may not authorize an inter partes review to be
instituted unless the Director determines that the information presented in the petition filed under
section 311 and any response filed under section 313 shows that there is a reasonable likelihood that the
petitioner would prevail with respect to at least 1 of the claims challenged in the petition.” 35 U.S.C. §
314(a) (2012); see also Harmonic Inc. v. Avid Tech., Inc., 815 F.3d 1356, 1367 (Fed. Cir. 2016)
(Section 314(a) provides that the PTAB may, not must, institute IPR); Conopco, Inc. v. Proctor &
Gamble Co., No. IPR2014-00506, Paper 25 at 4 (P.T.A.B. Dec. 10, 2014) (informative) (IPR institution
“is discretionary, not mandatory” under § 314(a)). See generally Kevin B. Laurence and Matthew C.
Phillips, PTAB’s Discretion to Deny Institution, in USPTO POST-GRANT PATENT TRIALS 2018 (2018),
available at https://www.ipo.org/wp-content/uploads/2018/04/9.15_Laurence_Kevin_Paper.pdf.
2. No. IPR2018-00752, Paper 8 (P.T.A.B. Sept. 12, 2018).
3. Precedential and Informative Decisions, USPTO, https://www.uspto.gov/patents-applicationprocess/patent-trial-and-appeal-board/precedential-informative-decisions (last visited Aug. 6, 2019).
Precedential opinions are binding on all members of the Board unless overcome by subsequent binding
authority. Note that on one hand, the PTAB’s “nearing completion” remark may have no legal
significance and be administratively amended/deleted at any time; on the other hand, the remark could
shed light on the PTAB’s thinking at the time of designating NHK Spring precedential.
4. Hormel Foods Corp. v. HIP, Inc., No. IPR2019-00469, Paper 9 at 50 (P.T.A.B. July 15,
2019). The PTAB applied the principle of NHK Spring even before designating it as a precedential
253
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precedential, the authors show that NHK Spring and its progeny5 have
important implications for both the timing of filing an IPR petition and
deciding whether to file a petition when trial in a parallel district court
proceeding draws near.
The article proceeds in six Parts. Part II lays out the procedural history
of NHK Spring. Part III discusses three PTAB cases before NHK Spring’s
precedential designation. Part IV discusses three PTAB cases after the
designation. Part V analyzes and synthesizes each case discussed in Parts II
through IV. Part VI briefly concludes with strategic considerations for
practitioners. The Appendix to this article summarizes the seven discussed
cases in a table format to help visualize the results and any possible trends.
II. NHK SPRING CO., LTD. V. INTRI-PLEX TECHS., INC. (DENYING
INSTITUTION; TRIAL SIX MONTHS AWAY)
In NHK Spring, the PTAB exercised its discretion under both §§
314(a) and 325(d)6 to deny institution due, inter alia, to a parallel district
court trial scheduled six months away.7 On March 2, 2017, Intri-Plex
Technologies, Inc. sued NHK International and its parent company, NHK
Spring, for infringement of U.S. Patent No. 6,183,841 in the Northern
District of California.8 Service was effected on March 9, 2017.9 On March
7, 2018 (two days before the one-year time bar deadline10), NHK Spring
petitioned for IPR.11 In its preliminary response, Intri-Plex asserted that an
IPR proceeding would be inefficient due to the parallel district court
proceedings.12
The PTAB agreed with Intri-Plex and denied institution on September
12, 2018, because the parallel district court trial was scheduled to be on
decision. For instance, in May 2019, the PTAB in E-One, Inc. v. Oshkosh Corp. denied institution under
§ 314(a) due to a parallel district court trial scheduled eleven months away. No. IPR2019-00161, Paper
16 at 9 (P.T.A.B. May 15, 2019).
5. Every case following NHK Spring, through August 15, 2019, has been identified by searching
PTAB Decisions on Institution in Docket Navigator for “IPR2018-00752, Paper 8” or “IPR2018-00752,
slip op.” The authors assessed each such case and have discussed below each as having a sufficient
substantive discussion of NHK Spring.
6. 35 U.S.C. § 325(d) (2012) (“[I]f another proceeding or matter involving the patent is before
the Office, the Director may determine the manner in which the [IPR] may proceed . . .”).
7. No. IPR2018-00752, Paper 8 (P.T.A.B. Sep. 12, 2018).
8. Intri-Plex Techs., Inc. v. NHK Int’l Corp., No. 3-17-cv-1097 (N.D. Cal. 2017).
9. NHK Int’l, No. 3-17-cv-1097, Dkt. 15 (Mar. 10, 2017).
10. See 35 U.S.C. § 315(b) (“An inter partes review may not be instituted if the petition
requesting the proceeding is filed more than 1 year after the date on which the petitioner, real party in
interest, or privy of the petitioner is served with a complaint alleging infringement of the patent.”).
11. NHK Spring, No. IPR2018-00752, Paper 1 (P.T.A.B. Mar. 7, 2018).
12. NHK Spring, No. IPR2018-00752, Paper 8 at 20 (P.T.A.B. Sept. 12, 2018).
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March 25, 2019, approximately six months after the denial.13 The PTAB
found that instituting under § 314(a) would be an inefficient use of
resources because Petitioner asserted the same prior art and arguments in
the district court proceeding.14 Additionally, the district court proceeding
was “nearing its final stages” and the advanced state of the district court
proceeding weighed in favor of denying the petition under § 314(a).15
In this instance, the PTAB’s “nearing its final stages” refers to the
parallel district court trial scheduled for six months away.16 And while
NHK Spring involved the PTAB’s exercise of its discretion to deny under
both §§ 314(a) and 325(d), it has been mostly cited for its discretion to
deny under § 314(a), though the denial on the § 325(d) ground has been
brought up in attempt to distinguish NHK Spring.17
III. BEFORE NHK SPRING’S PRECEDENTIAL DESIGNATION
1. Mylan Pharmaceuticals, Inc. v. Bayer Intellectual Property GmbH
(denying institution; trial four months away)
In Mylan, the PTAB exercised its § 314(a) discretion to deny
institution based on the fact that a district court trial was scheduled to begin
in four months, even though the Patent Owner did not raise the issue.18 On
May 19, 2017, Bayer Intellectual Property GmbH and its parent company,
Bayer AG, sued Mylan Pharmaceuticals Inc. for infringement of U.S.
Patent No. 9,539,218 in the District of Delaware.19 On May 24, 2018,
Mylan petitioned for IPR, asserting two grounds alleging obviousness.20 In
its preliminary response, Bayer argued that the PTAB should decline to
institute the IPR on both grounds under § 325(d) or alternatively

13. Id.
14. Id.
15. Id.
16. Id.
17. See, e.g., Intuitive Surgical, Inc. v. Ethicon LLC, No. IPR2018-01703, Paper 7 at 11–13 & nn.
7–8 (P.T.A.B. Feb. 19, 2019); Huawei Device Co., Ltd. v. Optis Wireless Tech., LLC, Nos. IPR201800653, IPR2018-00655, Paper 27 at 11 (P.T.A.B. Mar. 13, 2019). Intuitive Surgical is discussed in
detail in infra Part III.2.
18. No. IPR2018-01143, Paper 13 (P.T.A.B. Dec. 3, 2018).
19. Bayer Intellectual Property GmbH v. Mylan Pharms., Inc., No. 1-17-cv-584, Dkt. 1 (D. Del.
2017).
20. Mylan Pharma. Inc. v. Bayer Intellectual Prop. GmbH, No. IPR2018-01143, Paper 2 at 1–3
(P.T.A.B. May 24, 2018). As Mylan explained in the petition, it was served with the complaint in the
district court action “no earlier than May 24, 2017,” and thus the petition was filed within one year of
service, as permitted under 35 U.S.C. § 315(b). Id. at 14.
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§ 312(a)(3), but did not contend that the PTAB should exercise its
discretion to deny institution under § 314(a).21
In its Decision on Institution, issued on December 3, 2018, the PTAB
noted that a district court trial on the same patent was scheduled for April
1, 2019, less than four months away.22 Relying on NHK Spring, the PTAB
found that instituting IPR would be inefficient given the advanced stage of
the co-pending district court case and the extensive overlap between the
cases.23 Thus, the PTAB exercised its discretion under § 314(a) and
dismissed the relevant grounds in Bayer’s petition because of temporal
proximity of the district court trial.24 Mylan demonstrates the PTAB’s
willingness to deny institution, sua sponte, under § 314(a) due to the
temporal proximity of the parallel district court trial under NHK Spring.
2. Intuitive Surgical, Inc. v. Ethicon LLC (granting institution; trial
eight months away)
In Intuitive Surgical, the panel made clear its position that NHK
Spring did not endorse denying all IPR institutions solely because of
parallel district court proceedings.25 On June 30, 2017 Ethicon LLC,
Ethicon Endo-Surgery, Inc., and Ethicon US, LLC sued Intuitive Surgical,
Inc., Intuitive Surgical Operations, Inc., and Intuitive Surgical Holdings,
LLC for infringement of six patents, including U.S. Patent No. 8,616,431
(“‘431 Patent”), in the District of Delaware.26 On September 11, 2018,
Intuitive Surgical petitioned for IPR on the ‘431 Patent.27 In its preliminary
response, Ethicon argued that the PTAB should deny institution because
Intuitive Surgical delayed filing the IPR so that the district court would

21. Mylan, Paper 6 at 2–4 (P.T.A.B. Sept. 7, 2018) (citing 35 U.S.C. § 312(a)(3) (2012)
“Requirements of Petitions. A petition filed under section 311 may be considered only if . . . the petition
identifies, in writing and with particularity, each claim challenged, the grounds on which the challenge
to each claim is based, and the evidence that supports the grounds for the challenge to each claim,
including (A) copies of patents and printed publications that the petitioner relies upon in support of the
petition; and (B) affidavits or declarations of supporting evidence and opinions, if the petitioner relies
on expert opinions.”).
22. Id. at 14.
23. Id. at 13–14 (explaining that “given the advanced stage of the copending district court case
and the extensive overlap of the asserted prior art, expert testimony, and claim construction . . . it would
be an inefficient use of Board resources to proceed with this inter partes review in parallel with the
district court case”).
24. Id.
25. See generally No. IPR2018-01703 (P.T.A.B. filed Sep. 11, 2018).
26. Ethicon LLC v. Intuitive Surgical, Inc., No. 17-cv-871, Dkt. 1 (D. Del. June 30, 2017).
27. Ethicon, No. 17-cv-871, Dkt. 47 (D. Del. Nov. 13, 2017); Intuitive Surgical, No. IPR201801703, Paper 2 at 1 (P.T.A.B. Sept. 11, 2018).

DISCRETIONARY DENIALS OF IPR INSTITUTION

2019

DISCRETIONARY DENIALS OF IPR INSTITUTION

12/26/2019 5:35 PM

257

reach a decision before an IPR proceeding would, and cited NHK Spring to
argue that the PTAB should deny institution under § 314(a).28
The PTAB disagreed with Ethicon and instituted IPR on February 19,
2019, despite a parallel district court trial scheduled for October 15, 2019,
nearly eight months away.29 The PTAB explained there is no per se rule to
deny institution of an IPR whose final decision might issue after a district
court trial.30 In fact, according to the PTAB, instituting under these
circumstances might conserve judicial resources because it gives the
district court an opportunity to stay the litigation until the IPR proceeding
is complete.31 Moreover, because the petition was filed before November
13, 2018, the claims would be construed using the broadest reasonable
interpretation standard, which is a different standard from the one the
district court would apply.32 The PTAB further found that NHK Spring did
not require the PTAB to exercise its § 314(a) discretion solely because the
district court would review the same issues before the IPR proceeding
would be completed.33 Instead, the PTAB noted that in NHK Spring, the
PTAB could have denied institution based entirely on the § 325(d)
factors.34 Finally, the PTAB noted that “NHK Spring has not been
designated as either precedential or informative.”35
Thus, in Intuitive Surgical, the PTAB declined to deny institution
based on only the fact that the Final Written Decision would be issued after
the district court trial.
3. Amazon.com, Inc. v. CustomPlay, LLC (granting institution on one
of three asserted patents; trial five months away)
In Amazon, the PTAB declined to exercise its § 314(a) discretion to
deny institution of one of the three patents asserted at the district court,
despite a parallel district court trial scheduled five months away.36 On July
27, 2017, CustomPlay, LLC sued Amazon.com, Inc. for infringing three
patents, including U.S. Patent No. 9,380,282 (“‘282 Patent”), in the

28. Intuitive Surgical, No. IPR2018-01703, Paper 6 at 6, 41–43 (P.T.A.B. Dec. 21, 2018).
29. Intuitive Surgical, No. IPR2018-01703, Paper 7 at 28 (P.T.A.B. Feb. 19, 2019).
30. Id. at 11–12.
31. Id. at 12.
32. Id.
33. Id. at 13.
34. Id. at 12.
35. Id. at 12 n.7. However, this last statement was short-lived because the PTAB designated NHK
Spring precedential three months later. See Precedential, supra note 3.
36. See generally No. IPR2018-01498 (P.T.A.B. filed Aug. 1, 2018).
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Southern District of Florida.37 The Complaint was served on August 2,
2017.38 On August 1, 2018 (one day before the one-year time bar deadline),
Amazon.com filed an IPR petition challenging the ‘282 Patent.39 In its
preliminary response, CustomPlay cited NHK Spring to argue that
instituting IPR would not serve its purpose “as an alternative to litigation”
and would be inefficient given the advanced stage of the district court
proceeding.40
The PTAB disagreed with CustomPlay and instituted IPR of the ‘282
Patent on March 14, 2019 despite the parallel district court trial scheduled
for August 19, 2019 (five months away).41 The PTAB disagreed with
Patent Owner’s contention that the related district court case was at an
advanced stage to warrant denying institution.42 At that point, the parties
had not taken any fact depositions, there had been no claim construction
hearing, and the district court had recently granted a joint motion to extend
deadlines for discovery.43 This is distinguishable from NHK Spring where
the district court had already issued its claim construction order, and expert
discovery was set to end in less than two months.44 Thus, the PTAB
declined to exercise its § 314(a) discretion to deny institution.45
IV. AFTER NHK SPRING’S PRECEDENTIAL DESIGNATION
After NHK Spring was designated as precedential, patent owners cited
it more frequently, requesting that the PTAB exercise its § 314(a)
discretion. So far, the designation has not significantly affected the PTAB’s
responses to § 314(a) arguments.
1. E-One Inc. v. Oshkosh Corp. (denying institution; trial up to eleven
months away)
After NHK Spring was designated precedential on May 7, 2019,46 the
PTAB in E-One Inc. v. Oshkosh Corp. denied institution under § 314(a)
37.
2017).
38.
39.
2018).
40.
41.
42.
43.
44.
45.
46.

CustomPlay, LLC v. Amazon.com, Inc., No. 17-cv-80884, Dkt. 1 at 5 (S.D. Fla. July 27,
CustomPlay, No. 17-cv-80884, Dkt. 7 (Aug. 11, 2017).
Amazon.com, Inc. v. CustomPlay, LLC, No. IPR2018-01498, Paper 1 at 1 (P.T.A.B. Aug. 1,
Amazon.com, No. IPR2018-01498, Paper 6 at 9–10 (P.T.A.B. Dec. 18, 2018).
Amazon.com, No. IPR2018-01498, Paper 13 at 8 (P.T.A.B. Mar. 14, 2019).
Id. at 9.
Id. at 9–10.
Id. at 10.
Id. at 11.
Precedential, supra note 3.
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due to a district court trial scheduled ten to eleven months away.47 On
February 23, 2018, Pierce Manufacturing, a subsidiary of Oshkosh
Corporation, sued REV Group and E-One for infringement of U.S. Patent
Nos. 9,597,536 (“‘536 Patent”) and 9,814,915 (“‘915 Patent”) in the
Eastern District of Wisconsin (“Wisconsin Action”).48 REV Group and EOne responded on March 14, 2018, by filing a declaratory judgment action
on the two patents in the Middle District of Florida (“Florida Action”).49
The Wisconsin Action was transferred to the Middle District of Florida on
April 20, 2018, and consolidated with the Florida Action on May 2, 2018.50
A trial is scheduled for April 2020.51 On November 20, 2018 (less than
nine months after filing suit), E-One, REV Group, and others filed one IPR
petition on each of the two patents.52 In its preliminary responses, Oshkosh
and Pierce Manufacturing cited NHK Spring to argue that instituting IPR
would be inefficient given the status of the district court proceeding.53
The PTAB agreed with Oshkosh and Pierce Manufacturing in No.
IPR2019-00161 and denied institution of the ‘536 Patent on May 15, 2019
because the district court trial on the same patent was scheduled for eleven
months from the date of the institution decision. The PTAB chose to
exercise its § 314(a) discretion because there was significant overlap
between the IPR petition and the parallel district court case.54 Additionally,
the proceedings at the district court were at a significantly advanced
stage.55 For instance, while the IPR petitions were pending, the district
court already reviewed all the briefings related to, and granted decisions on,
preliminary injunction and claim construction.56 And the district court trial
would have concluded before a final decision would be due in the PTAB
proceeding if IPR was instituted.57
On June 5, 2019, the PTAB in No. IPR2019-00162 denied institution
of the ‘915 Patent under § 314(a) for the same reason – this time, the trial
was ten months away.58 In a more lengthy discussion of the parallel

47. No. IPR2019-00161, Paper 16 (P.T.A.B. May 15, 2019).
48. Pierce Mfg. v. REV Grp., No. 18-cv-284 (E.D. Wis. 2018).
49. Pierce Mfg. v. E-One, No. 18-cv-617 (M.D. Fl. 2018).
50. Pierce Mfg. v. REV Grp., No. 18-cv-976 (M.D. Fl. 2018).
51. E-One, No. 18-cv-617, Dkt. 43 (June 13, 2018).
52. E-One, No. IPR2019-00161 (P.T.A.B. Nov. 11, 2018) (‘536 Patent). See generally E-One,
No. IPR2019-00162, (P.T.A.B. Nov. 11, 2018) (‘915 Patent).
53. E-One, No. IPR2019-00161, Paper 9 at 14 (P.T.A.B. Mar. 6, 2019).
54. Id., Paper 16 at 6 (P.T.A.B. May 15, 2019).
55. Id. at 9.
56. Id. at 7.
57. Id. at 6.
58. Id., No. IPR2019-00162, Paper 16 at 8–9 (P.T.A.B. June 5, 2019).
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proceedings, the PTAB found that administering IPR would be inefficient
because of the significant overlap between the petition and the district court
case.59 The significant resources already spent on the co-pending litigation
meant instituting IPR would “not serve the objective of providing an
effective and efficient alternative to district court litigation.”60 Petitioner’s
arguments in this petition were essentially the same as those brought up in
the district court case.61 Furthermore, the PTAB found the petitioner’s
arguments “weak and speculative.”62 And the scheduled district court trial
would complete before any Final Written Decision would be due.63 Thus,
denying a petition under § 314(a) was in accordance with a balanced
assessment of the totality of the circumstances, including the merits.64
In its decision, the PTAB went into substantial detail on the many
overlaps between the petition and the parallel district court proceeding. EOne’s invalidity arguments in its petition relied on the same theory as the
one proposed in the Florida Action.65 After reviewing the expert witness
declarations, the PTAB found substantial overlap on expert testimony
between the petition and the Florida Action.66 Furthermore, since the
petition was filed after November 13, 2018, the Phillips standard applies to
both the district court and IPRs.67 The PTAB found that E-One’s
obviousness arguments were fundamentally the same as those presented in
the Florida Action and ultimately unconvincing.68 Thus, the PTAB decided
to exercise its § 314(a) discretion to deny institution based on the
substantial overlap between the parallel district court case and the relatively
weak merits of the petition.69
E-One is significant because the PTAB can still exercise its § 314(a)
discretion to deny institution due to a parallel district court trial scheduled
up to eleven months in the future.

59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.

Id. at 8.
Id. at 12–13.
Id. at 17.
Id. at 20.
Id.
Id. at 8.
Id. at 10.
Id. at 11.
Id. at 11–12.
Id. at 17.
Id. at 20.

DISCRETIONARY DENIALS OF IPR INSTITUTION

2019

DISCRETIONARY DENIALS OF IPR INSTITUTION

12/26/2019 5:35 PM

261

2. Apotex Inc. v. UCB Biopharma SPRL (granting institution; district
court case was stayed though trial and would have been one month away)
In Apotex, the PTAB chose to not exercise its§ 314(a) discretion to
deny institution because the district court proceeding was stayed pending
resolution of the IPR petition.70 On April 17, 2018, UCB, Inc. and UCB
Biopharma SPRL sued Apotex Inc. for infringement of U.S. Patent No.
8,663,194 in the Southern District of Florida.71 On December 13, 2018,
Apotex petitioned for IPR.72 The jury trial was initially scheduled for
August 19, 2019,73 but on April 1, 2019, the district court granted a stay
pending resolution of the IPR petition.74 In its preliminary response, UCB
cited Mylan and NHK Spring to argue that the PTAB should exercise its
§ 314(a) discretion and deny institution because of the co-pending district
court litigation.75 Additionally, UCB argued that if the status of the ‘194
Patent remained in flux after the 30-month regulatory stay, UCB would be
forced to “seek a preliminary injunction at the District Court where the
merits of the case will have to be reviewed because the Hatch-Waxman Act
empowers only District Courts to issue such injunctions.”76 UCB argued
that, from an efficiency standpoint, the entire case should be handled by the
district court.77
The PTAB disagreed with UCB and instituted IPR on July 15, 2019,
even though the initially-scheduled district court trial without the stay
would have been one month away.78 The PTAB distinguished Apotex from
NHK Spring and found that “the merits of the case weigh heavily in favor
of granting institution” and “the procedural posture of the related district
court litigation weighs against exercising [the PTAB’s § 314(a)] discretion
to deny institution.”79 In Apotex, the related district court proceeding is
stayed and administratively closed pending resolution of IPR. Thus, unlike
NHK Spring, the district court trial in Apotex could not occur before the
Final Written Decision.80 Additionally, the PTAB found that risk of a

70. No. IPR2019-00400, Paper 17 at 31–35 (P.T.A.B. July 15, 2019).
71. UCB Inc. v. Apotex Inc., No. 18-cv-60846, Dkt. 1 (S.D. Fla. Apr. 17, 2018).
72. Apotex, No. IPR2019-00400, Paper 3 (P.T.A.B. Dec. 13, 2018).
73. UCB, No. 18-cv-60846, Dkt. 28 (S.D. Fla. June 7, 2018).
74. Apotex, No. IPR2019-00400, Paper 17 at 29 (P.T.A.B. July 15, 2019); UCB, No. 18-cv60846, Dkt. 61 (S.D. Fla. Apr. 1, 2019).
75. Apotex, No. IPR2019-00400, Paper 11 at 27–28 (P.T.A.B. Apr. 16, 2019).
76. Id. at 30–31.
77. Id.
78. Apotex, No. IPR2019-00400, Paper 17 at 35 (P.T.A.B. July 15, 2019).
79. Id. at 31–35.
80. Id. at 30–32.
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possible preliminary injunction to be speculative.81 Finally, the PTAB
found that the AIA did not guarantee every IPR would be maximally
efficient and that litigants need not adopt inferior strategies simply to
increase efficiency.82
In Apotex, even though the district court trial was potentially only one
month away, the PTAB chose not to exercise its § 314(a) discretion
because the district court stayed the case pending IPR resolution. The
circumstances (e.g., an intervening stay order) may dictate the result of the
IPR petition.
3. Unified Patents Inc. v. Fall Line Patents, LLC (granting institution;
trial nine months away)
In Unified Patents, the PTAB chose not to exercise its § 314(a)
discretion to deny institution because, despite a parallel district court trial
scheduled nine months away, the Patent Owner did not provide sufficient
evidence on the progress of the district court proceeding nor the material
overlap between the two proceedings.83 On August 15, 2018, Fall Line
Patents separately sued multiple defendants in the Eastern District of Texas
for infringement of U.S. Patent No. 9,454,748.84 The defendants, along
with Unified Patents, petitioned for IPR on claims 1, 2, 5, 7, and 19–22.85
In its preliminary response, Fall Line Patents cited NHK Spring to argue
that the PTAB should exercise its § 314(a) discretion to deny institution
because the district court trial is set for May 2020, just nine months away
and well before a Final Written Decision is due.86
The PTAB disagreed with Fall Line Patents and instituted IPR on
August 7, 2019, despite the parallel May 2020 district court trial.87 Unlike
in NHK Spring, where the related district court case was in its final stages
and expert discovery was set to close in a few months, the PTAB found the
record “devoid of other evidence on the status of that case, such as the

81. Id.
82. Id. at 32–33.
83. No. IPR2019-00610, Paper 14 at 11 (P.T.A.B. Aug. 7, 2019).
84. Unified Patents, No. IPR2019-00610, Paper 7 at 1–2 (P.T.A.B. Jan. 22, 2019). They are:
American Multi-Cinema, Inc.; AMC Entertainment Holdings, Inc.; Boston Market Corporation; Mobo
Systems, Inc.; McDonald’s Corporation; McDonald’s USA; Panda Restaurant Group, Inc.; Panda
Express Inc.; Papa John’s International, Inc.; Star Papa LP; Papa John’s USA, Inc.; and Starbucks
Corporation.
85. Id. at 3.
86. Unified Patents, No. IPR2019-00610, Paper 14 at 9 (P.T.A.B. Aug. 7, 2019)
87. Id. at 11.
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progress of fact and expert discovery.”88 Also, the PTAB found that Fall
Line Patents did not provide any evidence on a significant overlap between
the petition and the related district court case, which overlap had been
present in NHK Spring.89 As such, failing to sufficiently support the NHK
Spring argument with more details and citations to the record (evidence)
can doom an otherwise-solid § 314(a) argument.
Unified Patents shows that patent owners advancing NHK Spring
arguments need to be thorough and detailed, with evidence and citations to
the record, to avoid non-institution owing merely to the absence of details
regarding the overlap in issues in the parallel proceedings and the stage of
the district court litigation.
V. ANALYSIS
NHK Spring’s precedential designation in May 2019 is fairly recent
and its effect on PTAB practice is still developing. While six post-NHK
Spring cases may not portend a long-term trend, to the extent one is
observable, the precedential designation does not appear to mark a shift in
PTAB practice regarding institution, though there seems to be a trend with
the co-pending district court trial dates appearing closer and closer to the
Final Written Decision dates for cases that were denied institution. The
precedential designation makes arguments citing NHK Spring more
persuasive, but based on what has happened thus far, arguments based on
NHK Spring and its progeny have found occasional, but not consistent,
success. Sometimes, like in Apotex Inc. v. UCB Biopharma SPRL,90 the
circumstances (e.g., an intervening stay order) dictate the result. In others,
like Unified Patents Inc. v. Fall Line Patents, LLC,91 NHK Spring
arguments may fail because of a lack of substantive support for such
arguments.
Given that the PTAB’s Final Written Decision is due “not more than
one year from the date a trial is instituted,”92 the term “nearing completion”
used by the PTAB in summarizing the NHK Spring holding93 appears to
mean that the PTAB can exercise its § 314(a) discretion to deny institution
due to a parallel district court trial scheduled almost one year away, as

88. Id.
89. Id.
90. No. IPR2019-00400, Paper 17 (P.T.A.B. July 15, 2019).
91. No. IPR2019-00610, Paper 14 at 11 (P.T.A.B. Aug. 7, 2019).
92. Office Patent Trial Practice Guide, 77 Fed. Reg. 48757 (Aug. 14, 2012) (to be codified at 37
C.F.R. pt. 42).
93. See Precedential, supra note 3.
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evident by E-One Inc. v. Oshkosh Corp.94 (denying institution due to a
district court trial eleven months away).
VI. CONCLUSION
It may be advisable for an alleged infringer to consider early IPR
petitions to try to preempt what may become a common attack in patent
owner preliminary responses. For example, the PTAB once hinted that a
petitioner might have escaped a § 314(a) denial if it had filed its IPR
“around the same time as the service of the initial invalidity contentions” in
the parallel district court proceeding.95 Of course, the feasibility of such
fast-track attacks will vary from case to case and may be sub-optimal in
some instances (e.g., where it is helpful to wait to take a claim construction
position in trial court to solidify a PTAB unpatentability ground).96 But
petitioners and patent owners should not assume that a petition is timely
merely because it is filed before the one-year time bar.97 In determining
when to file IPR petitions, petitioners should consider the status of any
related litigations. In particular, if a related litigation is pending in a
relatively fast venue, petitioners may want to file an IPR petition on an
expedited schedule, well before the one-year deadline. Patent owners, on
the other hand, should consider challenging the timing of a “timely” IPR
petition if the IPR proceeding would conclude after (or about the same time
as) the scheduled district court trial. Patent owners might also argue that the
parallel proceedings are duplicative and, therefore, a waste of judicial
resources, and have the potential to produce inconsistent results.

94. No. IPR2019-00161, Paper 9 (P.T.A.B. Mar. 6, 2019).
95. Next Caller Inc. v. TRUSTID, Inc., No. IPR2019-00961, Paper 10 at 16 (P.T.A.B. Oct. 16,
2019) (denying institution).
96. Office Patent Trial Practice Guide, 77 Fed. Reg. at 48757.
97. 35 U.S.C. § 315(b) (2012).
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Appendix: Summary of Cases Nearing Trial at Time of Institution
Decision
Case

Institution
Decision Date

Result of
Institution
Decision

Time to
District Court
Trial as of
Institution
Decision

NHK Spring Co., Ltd.
v. Intri-Plex Techs.,
Inc.98
Pre-Designation Cases
Mylan
Pharmaceuticals, Inc.
v. Bayer Intellectual
Property GmbH99
Intuitive Surgical, Inc.
v. Ethicon LLC100
Amazon.com, Inc. v.
CustomPlay, LLC101
Post-Designation Cases
E-One Inc. v. Oshkosh
Corp. 102
Apotex Inc. v. UCB
Biopharma SPRL103

Sept. 12, 2018

Denied

6 months

Months after
Trial that
Final Written
Decision
Would Be
Due
6 months

Dec. 13, 2018

Denied

4 months

8 months

Feb. 19, 2019

Granted

8 months

4 months

Mar. 14, 2019

Granted

5 months

7 months

May 15, 2019;
June 5, 2019
July 15, 2019

Denied

Approx. 1
month
Before district
court trial

Unified Patents Inc. v.
Fall Line Patents,
LLC104

Aug. 7, 2019

Granted

Up to 11
months
Case stayed
(trial originally
scheduled for 1
month after
inst. decision)
9 months

98.
99.
100.
101.
102.
103.
104.

Granted

No. IPR2018-00752, Paper 8 (P.T.A.B. Sep. 12, 2018).
No. IPR2018-01143, Paper 13 (P.T.A.B. Dec. 13, 2018).
No. IPR2018-01703, Paper 7 (P.T.A.B. Feb. 19, 2019).
No. IPR2018-01498, Paper 13 (P.T.A.B. Mar. 14, 2019).
No. IPR2019-00161, Paper 16 (P.T.A.B. May 15, 2019).
No. IPR2019-00400, Paper 17 (P.T.A.B. July 15, 2019).
No. IPR2019-00610, Paper 14 (P.T.A.B. Aug. 7, 2019).
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